Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Novartis AG ADS
(NY:
NVS
)
74.15
USD
-0.86 (-1.15%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Novartis AG ADS
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
AnalystChoice.com Brings You the Best Complimentary Research Report on MDU, NVS, BKS, MA, NGD and NBR
August 13, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
Beacon Equity Issues Trading Outlook for Ariad Pharmaceuticals Inc.
July 30, 2009
from
GlobeNewswire News Releases
Beacon Equity Issues Investment Report for Aradigm Corp
July 20, 2009
from
GlobeNewswire News Releases
Beacon Equity Issues Investment Report for Keryx Biopharmaceuticals Inc.
July 17, 2009
from
GlobeNewswire News Releases
BridgewaterEquity.com Free Fundamental Sector & Market Research on ME, OSK, RSH, AZO, NVS and DRH
July 16, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE).
Read More
from
Marketwired News Releases
Beacon Equity Issues Trading Outlook for Amgen Inc.
July 15, 2009
from
GlobeNewswire News Releases
Penny Stock Chaser Announces Investment Opinion on AXL, SOL, YRCW, RIGL and HEB
July 09, 2009
from
Business Wire News Releases
BenchmarkJournal.com Free Analyst Review for AOD, NVS, BDK, MHK, BEE and CNI
July 01, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal.
Read More
from
Marketwired News Releases
AnalystChoice.com Brings You the Best Complimentary Research Report on NVS, SNDK, PCLN and ORCL
June 10, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
TheFortuneFinancial.com Initializes Free Analyst Research on NVS, OHI, PBG and GLBL
May 19, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.
Read More
from
Marketwired News Releases
Stock Alerts for CSCO, VLO, NVS, AMP, and NTES Released by Seven Summits Research
May 07, 2009
from
PR Newswire
AnalystChoice.com Free Investment Opinion on SO, NVS, PHK and ARE
April 22, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
Zacks Analyst Blog Highlights: GlaxoSmithKline, Johnson & Johnson, Novartis AG, IBM Corp. and Schering-Plough Corp.
April 22, 2009
from
Business Wire News Releases
Zacks Analyst Blog Highlights: Infinity Pharmaceuticals Inc, Novartis, Pfizer, OmniVision Technologies Inc and Google
April 17, 2009
from
Business Wire News Releases
Zacks Sell List Highlights: Ternium, City National Corp., Novartis and IDEX Corp.
February 27, 2009
from
Business Wire News Releases
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK
February 18, 2009
from
PR Newswire
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
February 17, 2009
from
PR Newswire
Ipsen announces the signature of a co-promotion agreement with Novartis for Exforge® in France
January 28, 2009
from
Business Wire News Releases
Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
January 27, 2009
from
PR Newswire
BenchmarkJournal.com (Complimentary) Analyst Updates for FRE, FNM, NVS and RF
January 21, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal.
Read More
from
Marketwired News Releases
Peptimmune Grants Major Pharmaceutical Company Exclusive Option to License PI-2301 for Multiple Sclerosis
January 15, 2009
from
PR Newswire
Seven Summits Research Releases Comments on MS, MON, NVS, CAJ, and PLCM
January 07, 2009
from
PR Newswire
BridgewaterEquity.com Free Fundamental Sector & Market Research on NVS, JNJ, GM and DOW
December 29, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE).
Read More
from
Marketwired News Releases
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: BMY, JNJ, PFE, NVS, GSK, ABT
December 17, 2008
from
PR Newswire
New Data Show Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumor Size
December 11, 2008
from
PR Newswire
IR Global Rankings 2009: Final Registration Deadline Is Today - November 28, 2008
November 28, 2008
from
PR Newswire
IR Global Rankings 2009: Registration FINAL Deadline Today
November 28, 2008
from
PR Newswire
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
November 20, 2008
from
PR Newswire
IR Global Rankings 2009: Registration Period Extended Until November 28, 2008
November 17, 2008
from
PR Newswire
Registration Period for the 2009 IR Global Rankings Ends Today
November 14, 2008
from
PR Newswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here